Amiel Gross

Amiel Gross currently serves as Head of Legal at the Center for Breakthrough Medicines in Philadelphia, focusing on building and managing their legal functions. He is responsible for ensuring the business strategies and policies are aligned with all risks taken into consideration. Counselling executives and senior management, negotiating complex commercial transactions, facilitating strategic alliances, supporting a range of legal issues arising during highly-regulated biotechnology business operations - these topics highlight his work as an attorney who specialises in cell & gene therapy manufacturing.

This professional oversight responsibility and hands-on experience across an array of subjects. These subjects include licensing deals, master services agreements, procurement contracts, intellectual property, corporate affairs, sponsored R&D collaborations, FDA regulatory and compliance, litigation, labour and employment, cyber-security and privacy.

Amiel Gross studied International Law at the Queen Mary University of London. He holds a Bachelor of Arts Degree from Southwestern University and a Doctor of Law Degree from The University of Texas School of Law.

His skills include general corporate counsel, life science industry, biotechnology, industry knowledge, pharmaceutical law, bio pharmaceuticals, corporate law, licensing, regulatory compliance. He is also highly experienced at business transactions, commercial contracts, CDMO, CGT, cell and gene therapy.

  Philadelphia, PA, USA  https://www.crunchbase.com/person/amiel-gross